Rosemary Sharon Harrison

Title: The Innovative Contributions of Rosemary Sharon Harrison

Introduction

Rosemary Sharon Harrison is a notable inventor based in Bondi Junction, Australia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of nociceptin peptide mimetics. Her work focuses on the modulation of the opioid receptor-like-1 (ORL-1) receptor, which has important implications for treating various diseases.

Latest Patents

Harrison holds a patent for her invention titled "Nociceptin mimetics." This patent describes nociceptin peptide mimetics that possess α-helical structures and are designed to bind to and modulate the ORL-1 receptor. The peptide mimetics are constrained cyclic nociceptin analogs that exhibit either agonist or antagonist activity. Additionally, the patent outlines pharmaceutical compositions that include these nociceptin peptide mimetics and methods for treating or preventing conditions that can be ameliorated by modulating the ORL-1 receptor. Harrison has 1 patent to her name.

Career Highlights

Harrison is affiliated with The University of Queensland, where she conducts her research and development work. Her academic and professional journey has been marked by a commitment to advancing the understanding of nociceptin and its potential therapeutic applications.

Collaborations

Throughout her career, Harrison has collaborated with esteemed colleagues, including David P Fairlie and Nicholas E Shepherd. These collaborations have enriched her research and contributed to the advancement of knowledge in her field.

Conclusion

Rosemary Sharon Harrison's innovative work in nociceptin peptide mimetics showcases her dedication to pharmaceutical research and development. Her contributions have the potential to impact the treatment of various conditions, highlighting the importance of her work in the scientific community.